Cornerstone Capital’s Nephros NEPH Stock Holding History

Cornerstone Capital’s Portfolio NEPH Stock Details NEPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$459K	Hold	128,700	–	–	0.04%	88
2026 Q1	$384K	Buy	+128,700	New	+$514K	0.04%	89

Other funds holding NEPH

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bard Associates Chicago, Illinois $451M AUM 66.6% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

MFIM

Mesirow Financial Investment Management Chicago, Illinois $6.37B AUM 23.22% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return

Navellier & Associates Reno, Nevada $1.26B AUM 95.39% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Cornerstone Capital's NEPH Position: Q2 2026 in Review

Cornerstone Capital held its Nephros (NEPH) position steady in Q2 2026 at 128,700 shares worth $459K. The position accounts for 0.04% of the portfolio, ranked #88.

Cornerstone Capital first reported a position in NEPH in Q1 2026 and has held it in 2 quarters since. 29 funds tracked by Wall St. Rank hold NEPH as of Q2 2026.

Cornerstone Capital held 128,700 shares of Nephros worth $459K as of Q2 2026.
Cornerstone Capital left its Nephros share count unchanged in Q2 2026.
Nephros made up 0.04% of Cornerstone Capital's portfolio in Q2 2026, its #88 holding.
Cornerstone Capital first reported a position in Nephros in Q1 2026 and has held it in 2 quarters since.
29 funds tracked by Wall St. Rank held Nephros as of Q2 2026.

Based on Cornerstone Capital's 13F filing for Q2 2026, filed 3 Aug 2026.